Holen Sie sich die Stockscreener-App
0.6942
2.65%
0.0179
Finanzdaten der Verrica Pharmaceuticals Inc-Aktie (VRCA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
92.45%
3.826
|
1.988 | 2.917 | 0.182 | 0.037 |
| Cost Of Revenue |
250.00%
0.70
|
0.20 | 0.30 | - | - |
| Gross Profit |
74.83%
3.126
|
1.788 | 2.617 | - | - |
Operating Expenses
|
10.74%
22.43
|
25.12 | 26.83 | 11.80 | 7.126 |
| Interest Income/Expense |
0.61%
2.319
|
2.305 | 1.657 | - | - |
| Benefits Costs and Expenses |
9.19%
24.16
|
26.60 | - | - | 6.626 |
| Costs And Expenses |
9.19%
24.16
|
26.60 | 26.83 | 11.80 | 6.626 |
| Operating Income/Loss |
19.61%
-18.60
|
-23.14 | -23.92 | -11.62 | -7.089 |
| Nonoperating Income/Loss |
17.19%
-1.732
|
-1.478 | -0.885 | 0.626 | 0.50 |
| Income/Loss From Continuing Operations Before Tax |
17.40%
-20.33
|
-24.61 | 2.917 | -10.99 | -6.589 |
| Income/Loss From Continuing Operations After Tax |
17.40%
-20.33
|
-24.61 | -24.80 | -10.99 | -6.589 |
|
Net Income/Loss
|
17.40%
-20.33
|
-24.61 | -24.80 | -10.99 | -6.589 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
14,135%
46.48
|
0.3266 | 46.07 | 45.92 | 43.02 |
| Diluted Average Shares |
14,135%
46.48
|
0.3266 | 46.07 | 45.92 | 43.02 |
| Basic Earnings Per Share |
18.52%
-0.44
|
-0.54 | -0.54 | -0.24 | -0.15 |
| Diluted Earnings Per Share |
18.52%
-0.44
|
-0.54 | -0.54 | -0.24 | -0.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):